UNSPSC 85494613: Supplement superior vena cava with autologous tissue substitute, percutaneous approach
Commodity
Code facts
- Part of
-
-
85000000
-
85490000
- 85494600
-
85490000
-
85000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 85494613
| NIGP code |
|---|
| 94857 Medical Services, Surgical |
Definition
This classification denotes the group of activities that yields a surgical intervention or procedure to supplement superior vena cava with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02UV37Z
About UNSPSC 85494613
UNSPSC 85494613 Supplement superior vena cava with autologous tissue substitute, percutaneous approach is a Commodity code whose nominal scope describes a specific surgical procedure; the recent state and local contract opportunities posted under this code show little alignment with that clinical description. The opportunities instead encompass medical evaluation services, pharmacy benefit management, occupational health surveillance, surgical benefit program carve-outs, emergency medical services contracting, and temporary health professional staffing—none of which relate to superior vena cava repair. The issuing bodies are diverse: county health systems and counties (Santa Clara County, Harris County, Collier County), municipal retirement boards (City of Phoenix), state departments (Washington State Department of Transportation), and cities (City of Long Beach). No repeat buyers appear across the opportunities; each issuer solicited once under this code during the review window.
The recent activity spans Arizona, California, Florida, and Washington. Representative solicitations include the City of Phoenix Retirement Office's RFP for independent medical evaluation services with a $750,000 maximum compensation over five years and proposals due October 16, 2026; the Washington State Department of Transportation's request for occupational medical surveillance services across 14 ferry system locations statewide with proposals due October 9, 2026 and a pre-bid conference scheduled for August 31, 2026; the City of Long Beach's RFP for surgical and medical procedure carve-out benefits for approximately 3,800 enrolled plan members with proposals due October 7, 2026 and contract execution targeted for April 1, 2027; and the County of Santa Clara Health System's solicitation for a non-exclusive qualified vendor pool for temporary health professional staffing services across 13 ancillary clinical categories with proposals due October 7, 2026. The code appears to be a tagging anomaly rather than an active procurement category aligned with its clinical definition.
Quick answers
What is UNSPSC 85494613?
UNSPSC 85494613 is Supplement superior vena cava with autologous tissue substitute, percutaneous approach, a commodity in UNSPSC 85000000, Healthcare Services.
Which NIGP codes match UNSPSC 85494613?
UNSPSC 85494613 maps to 1 NIGP code, 94857 Medical Services, Surgical.
On GovTribe
See everything under UNSPSC 85494613
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code